AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP and COO Michel Dahan sold $47K of Akebia Therapeutics, Inc.
Sold$46,637
$2.17Price
21,533Shares
−7%Stake
What AKBA did after the filing
- The stock from Thu, Mar 3 open, $2.47
- −78.2%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Apr 14 close.
Traded Mon, Feb 28. Filed Wed, Mar 2, 4:11 PM ET, after the close. Returns use the Mar 3 open and the Apr 14 close. Not investment advice.